IRCT201107216907N2已完成未知
Cinnarizine versus placebo in pediatric migraine prophylaxis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 17 years（—）
- 性别
- All
入选标准
- •1. Patients with migraine (with or without aura), diagnosed according to the International Headache society criteria. 2. Patients who had one or more migraine attack per week ; or sever dysfunction in daily and school activities during prospective baseline phase. 3. Headaches must not relate to any known structural brain lesion or other systemic conditions. Exclusion criteria: 1. Chronic headache, complications of migraine or other migraine variant. 2. Children and adolescents with Focal neurologic deficit. 3. History of diagnosed sensitivity to cinnarizine . 4. Patients who showed sever adverse effect to the study treatment drugs (in the double-blind phase of the study). 5. Serious comorbidities (hepatic, renal, cardiovascular or thyroid disease). 6. Patients who took prophylactic therapy for migraine within 4 weeks before study.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study of Lasmiditan in Pediatric Patients for acute treatment of migraineMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraineEUCTR2019-004378-24-FREli Lilly and Company1,633
进行中（未招募）
1 期
A study of Lasmiditan in Pediatric Patients for acute treatment of migraineMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraineEUCTR2019-004378-24-GBEli Lilly and Company1,633
进行中（未招募）
1 期
A study of Lasmiditan in Pediatric Patients for acute treatment of migraineMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraineEUCTR2019-004378-24-BEEli Lilly and Company1,633
进行中（未招募）
1 期
A study of Lasmiditan in Pediatric Patients for acute treatment of migraineMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraineEUCTR2019-004378-24-DEEli Lilly and Company1,633
进行中（未招募）
1 期
A study of Lasmiditan in Pediatric Patients for acute treatment of migraineMigraineEUCTR2019-004378-24-ITELI LILLY & COMPANY, LILLY CORPORATE CENTER1,633